Blackstone Inc’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2,375,037
Closed -$85.4M – 212
2022
Q4
$85.4M Hold
2,375,037
– – 0.32% 33
2022
Q3
$35.7M Hold
2,375,037
– – 0.13% 44
2022
Q2
$31.8M Sell
2,375,037
-61,695
-3% -$979K 0.11% 52
2022
Q1
$47M Sell
2,436,732
-938,305
-28% -$19.5M 0.12% 64
2021
Q4
$80M Hold
3,375,037
– – 0.2% 59
2021
Q3
$67.6M Buy
+3,375,037
New +$72.4M 0.15% 69

Blackstone Inc's IMGO Position: Q1 2023 in Review

Blackstone Inc sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 2,375,037 shares — an estimated $85.4M sold.

Blackstone Inc first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $85.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Blackstone Inc reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Blackstone Inc sold 2,375,037 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $85.4M.
  • Blackstone Inc first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
  • Blackstone Inc's Imago BioSciences, Inc. Common stock position peaked at $85.4M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Blackstone Inc's 13F filing for Q1 2023, filed 15 May 2023.